PF-562271 HCl for FAK/Pyk2 Cancer Studies
2026-09-05
PF-562271 HCl provides a selective, reversible way to interrogate FAK/Pyk2 signaling in adhesion, migration, tumor growth, and metastasis assays. When paired with the reference study on IFNγ-driven ERK apoptosis, it helps researchers distinguish focal-adhesion signaling effects from cytokine-induced death mechanisms.
Kidney Progenitor Assembloids for Disease Modeling
2026-09-05
Huang and colleagues developed spatially patterned mouse and human kidney progenitor assembloids that reproduce key aspects of nephron–collecting-system self-assembly, maturation, and function. Their in vivo-grown PKD2-deficient human model provides a more physiologically organized platform for studying polycystic kidney disease and pathogenic interactions among epithelial, stromal, and immune cells.
Necrosulfonamide: Reliable Necroptosis Assay Design
2026-09-04
This scenario-driven guide explains how Necrosulfonamide, SKU B7731, can improve mechanistic interpretation in necroptosis assays by separating MLKL phosphorylation from membrane translocation and cell death outcomes. It combines product specifications with findings from a 2025 cardiac microvascular ischemia–reperfusion study to support practical assay design, optimization, and vendor evaluation.
UK-5099 for Immunometabolism Assays
2026-09-04
UK-5099, also called PF-1005023, provides a focused way to test how mitochondrial pyruvate entry shapes cytokine production, cellular energy status, and glucose handling. This guide converts the standardized whole-blood stimulation framework into practical workflows with concentration planning, orthogonal readouts, and troubleshooting controls.
Solanesol (B8776): Practical Workflow Guide
2026-09-03
Solanesol (SKU B8776) provides a defined polyisoprenoid alcohol for biochemical workflows where hydrophobic compound handling, solvent compatibility, and precipitation control are important. It is suitable for controlled research applications but is insoluble in water and ethanol, so it should not be added directly to aqueous or ethanol-only systems.
BIRC2 and BIRC3 Regulation in Pulmonary Epithelium
2026-09-02
The reference study distinguishes how inflammatory cytokines and glucocorticoids regulate the anti-apoptotic signaling genes BIRC2 and BIRC3 in pulmonary epithelial models. Its findings position constitutive BIRC2 as a rapid signaling component, while inducible BIRC3 may provide later and glucocorticoid-resilient protection during airway inflammation.
SmD2 Acetylation Links Splicing to PARP Response
2026-09-02
A 2024 Nature Communications study identifies SmD2 acetylation as a regulatory link between core spliceosome stability, BRCA1/FANC cassette-exon usage, and DNA-damage repair in hepatocellular carcinoma. The work provides a mechanistic rationale for combining HDAC inhibition with olaparib to increase PARP-inhibitor sensitivity in preclinical HCC models.
HOBt for Peptide Coupling: Workflow and Troubleshooting
2026-09-02
HOBt supports mild, stereochemically controlled amide bond formation across peptide synthesis and medicinal chemistry workflows. This guide translates the reagent logic used in indazole glucagon receptor antagonist discovery into practical setup, optimization, and troubleshooting decisions.
Cefiderocol Activity in Resistant European Non-Fermenters
2026-09-01
This European multicenter study directly compared cefiderocol with established and emerging β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and newer combination therapies. Cefiderocol retained high in vitro activity across most resistant groups, while PCR and whole-genome sequencing identified resistance-associated β-lactamase and iron-transport pathway patterns that support parallel susceptibility testing.
EZ Cap™ EPO mRNA: Research Guide
2026-08-31
EZ Cap™ EPO mRNA is an approximately 855-nucleotide, Cap 1-capped human erythropoietin mRNA for research workflows. Its pseudouridine, poly(A) tail, and formulation are designed to support translation, mRNA stability enhancement, and controlled mammalian-cell expression, but the product does not itself establish therapeutic efficacy.
SmD2 Acetylation Links Splicing to PARP Sensitivity
2026-08-31
The 2024 Nature Communications study identifies acetylation-dependent control of the core spliceosome protein SmD2 as a link between alternative splicing, DNA-damage repair, and PARP-inhibitor response in hepatocellular carcinoma. Its preclinical data support investigating HDAC2-directed modulation with olaparib and position SmD2-regulated BRCA1/FANC cassette exons as mechanistic biomarkers.
Puromycin dihydrochloride: Reliable Cell Selection
2026-08-30
Learn how Puromycin dihydrochloride, SKU B7587, can improve selection design, translation studies, and cytotoxicity assay interpretation. This scenario-based guide connects concentration, solubility, storage, and workflow decisions to more reproducible laboratory practice.
Deuterium-Labeled Degarelix: Efficient 13-Step Synthesis
2026-08-29
This study reports a practical synthesis of deuterium-labeled degarelix acetate using D2O/D3PO4-mediated labeling followed by peptide assembly. The 13-step route delivered the labeled antagonist in 14% overall yield, providing a chemically defined candidate internal standard for pharmacokinetic and metabolism studies.
Neuromedin S (rat): GPCR Assay Workflow
2026-08-28
Neuromedin S (rat) provides a defined rat peptide agonist for controlled neuromedin U receptor signaling and GPCR/G protein assays, with dossier-based guidance for solubility, storage, and solution handling. It is intended for scientific research workflows only, not diagnostic, therapeutic, or medical use, and no directly matched paper evidence is used here to assign assay doses or predict biological outcomes.
Hoechst 33258 Workflows for KRas Tumor Studies
2026-08-28
Use Hoechst 33258 as more than a nuclear counterstain: it can anchor cell counts, DNA-content measurements, and spatial interpretation in KRas heterogeneity experiments. This guide connects live-cell imaging, fixed-cell validation, flow cytometry, and TNT-focused mechanical assays while emphasizing controls that prevent nuclear fluorescence from being mistaken for oncogenic protein transfer.
459 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page